What’s Next
- Medical Guidelines: The Department of Health and Human Services is expected to issue detailed advisories for physicians in the coming months.
- Insurance Litigation: Plaintiffs’ attorneys will likely test theories of liability against drugmakers, pharmacies, and insurers before year’s end.
- Coverage Updates: Insurers are already quietly revising policy language to hedge against expanded autism claims. Expect new exclusions, endorsements, or litigation over what counts as “medically necessary” autism treatment.
For families and the insurance industry alike, the next chapter may be written not just in science journals but in courthouses across America.
Sources
- White House Press Release (Sept. 22, 2025)
- Harvard T.H. Chan School of Public Health – NIH-funded review on acetaminophen and neurodevelopment
- Johns Hopkins University research findings
- Mount Sinai Hospital study results
- International Consensus Statement (Nature Reviews Endocrinology, Sept. 2021)
